1.Pubertal growth spurt peak in angle class I and II Malocclusions using cervical vertebrae maturation analysis in Deutero-Malay children
Putry Mahendra ; Seno Pradopo ; Mega Moeharyono Puteri
Acta Medica Philippina 2022;56(10):57-61
Background:
The incidence rate of Angle Class I and Class II malocclusions in mixed dentition is higher than Class III. In orthodontic interceptive treatment, it is necessary to identify pubertal growth spurt peak individually because the best growth modification could be obtained during this period. One of the methods in assessing the pubertal growth spurt peak is cervical vertebrae maturation (CVM), which is done using a lateral cephalometric radiograph. CVM evaluates potential growth and skeletal maturity by assessing cervical vertebrae anatomy. Identifying the duration of growth spurt peak on both malocclusion classes is the most pivotal aspect of optimizing remodeling and correction of children’s malocclusion.
Objective:
Distinguishing the duration of pubertal growth spurt peak of children with Angle Class I and II malocclusions based on CVM analysis in Deutero-Malay children so that it can be used in determining optimal orthodontic treatment plan and timing in children with Class I and Angle II malocclusion for Deutero-Malay children.
Methods:
Analytical observational with cross-sectional approach was applied using lateral cephalometric radiographic images from patients’ medical records attending or had attended orthodontic treatment in the Pediatric Dentistry Clinic, Airlangga University Dental Hospital, Surabaya, Indonesia, in 2014-2019 that met the inclusion criteria and were analyzed with Baccetti’s method of CVM analysis. This study involved 66 conventional lateral cephalometric photographs that were selected using total sampling. The data were analyzed using Independent T-Test and Mann Whitney U Test.
Result:
The duration of pubertal growth spurt peak in Angle Class I and II malocclusions was 11 and 7 months, respectively. The age of onset for Class I with CS3 was 9 years and 5 months, while for Angle Class II malocclusion starts entering the stage at 10 years 3 months of age, while for CS4 skeletal maturity we found that the age of onset for subjects with Angle Class I and II were 11 years 2 months and 12 years 4 months, respectively. The average duration of the pubertal growth spurt peak in female and male patients was 11.3 months and 18.2 months, respectively. All of these results were statistically significant (p ≤ 0.001) and representative of the population, in this case, Deutero-Malays.
Conclusion
Four-month differences in the duration of pubertal growth spurt peak of children with Angle Class I and II were found. This may lead to a shorter treatment duration of 4 months in children with Angle Class II malocclusion when compared to children with Angle Class I malocclusion. Angle Class II malocclusion exhibit shorter pubertal growth spurt peak duration, which may account for the difference in mandibular growth on the two malocclusion classes.
Puberty
;
Malocclusion
;
Malocclusion, Angle Class I
;
Malocclusion, Angle Class II
;
Cervical Vertebrae
;
Age Determination by Skeleton
;
Cephalometry
;
Asian People
;
Age of Onset
3.Analysis of DFNA5 gene variant in a Chinese pedigree affected with late-onset non-syndromic hearing loss.
Nuoyang WANG ; Canming CHEN ; Ming TONG ; Qian LI ; Li LIU ; Suwei HU
Chinese Journal of Medical Genetics 2021;38(2):174-177
OBJECTIVE:
To explore the genetic basis for a Chinese pedigree affected with autosomal dominant late-onset non-syndromic hearing loss (NSHL).
METHODS:
Clinical data of the pedigree were collected. Genomic DNA was extracted from peripheral blood samples of the proband and other family members. Trio whole exome sequencing was carried out for 19 396 genes to identify potential pathogenic variants. Sanger sequencing was carried out to verify the candidate variant in the pedigree.
RESULTS:
The proband and his father were found to carry a c.1183+1delG p.? variant of the DFNA5 gene. The variant was confirmed to be co-segregating with the disease phenotype in the pedigree.
CONCLUSION
The c.1183+1delG p.? variant of the DFNA5 gene probably underlay the late onset NSHL in this pedigree. Above finding has enabled accurate genetic counseling for this pedigree.
Age of Onset
;
China
;
Hearing Loss, Sensorineural/genetics*
;
Humans
;
Male
;
Mutation
;
Pedigree
;
Receptors, Estrogen/genetics*
4.Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study.
Jia Li CHEN ; Yue Bo JIN ; Yi Fan WANG ; Xiao Ying ZHANG ; Jing LI ; Hai Hong YAO ; Jing HE ; Chun LI
Journal of Peking University(Health Sciences) 2020;52(6):1040-1047
OBJECTIVE:
To investigate the clinical characteristics of patients with elderly-onset rheumatoid arthritis (EORA), and the risk factors of EORA complicated with cardiovascular disease (CVD).
METHODS:
A cross-sectional study was conducted in Peking University People's Hospital from July 2009 to December 2014 and 1 116 patients were recruited. The patients' characteristics and CVD, including ischemic heart disease, cerebral and peripheral vascular disease, were recorded. The patients were divided into EORA group (n=212) and younger-onset rheumatoid arthritis (YORA) group (n=904) according to the age of onset ≥60 years and < 60 years. Then, the differences between the groups were analyzed by Student's t test, Mann-Whitney U test or χ2test, and risk influencing CVD were analyzed using Logistic regression.
RESULTS:
There was no significant difference in the disease activity between the EORA and YORA groups. The proportion of male, pulmonary interstitial disease (ILD), and numbers of deformity joint count (DJC) were significantly higher in the EORA group compared with the YORA group [32.1% vs. 18.5%, χ2=19.11, P < 0.001; 23.6% vs. 13.6%, χ2=16.50, P < 0.001; 6 (2, 12) vs. 3 (2, 7), Z=-3.60, P < 0.001], while the prevalence of Sjögren's syndrome was lower than that of the YORA group (13.5% vs. 5.2%, χ2=11.29, P=0.001). Moreover, there were lower prevalences in the patients treated with disease-modifying antirheumatic drugs (DMARDs) in EORA group (35.4%) than in YORA group (26.7%) (χ2=6.43, P=0.011), especially in methotrexate (MTX), hydroxychloroquine (HCQ) and sulfasalazine (SSZ). In addition, the patients with EORA had a higher prevalence of CVD (27.8%) than the YORA group (11.6%, χ2=40.46, P < 0.001), accompanied with higher prevalence of smoking, hypertension, and hyperlipidemia. Multivariate Logistic regression analysis showed that elder age (OR=1.10, 95%CI: 1.00-1.20), DJC (OR=3.17, 95%CI: 1.04-9.68), rheumatoid nodules (OR=3.56, 95%CI: 1.03-12.23), hypertension (OR=2.37, 95%CI: 1.09-5.13) and hyperlipidemia (OR=8.85, 95%CI: 2.50-31.27) were independent risk factors, while HCQ (OR=0.22, 95%CI: 0.07-0.70) and MTX (OR=0.32, 95%CI: 0.14-0.73) were protective factors of EORA complicated with CVD.
CONCLUSION
Compared with YORA, patients with EORA have higher ratio of male, ILD and DJC, which may be attributed to inappropriate therapies. EORA is more likely to be complicated with CVD than YORA. Elder age, DJC, rheumatoid nodules, hypertension, and hyperlipidemia are independent risk factors, while HCQ and MTX are protective factors of EORA complicated with CVD.
Age of Onset
;
Aged
;
Antirheumatic Agents/therapeutic use*
;
Arthritis, Rheumatoid/epidemiology*
;
Cardiovascular Diseases/etiology*
;
Cross-Sectional Studies
;
Humans
;
Male
;
Risk Factors
5.Accurate use of antibiotics for preterm infants with early-onset sepsis should be taken seriously.
Chinese Journal of Contemporary Pediatrics 2020;22(1):7-8
At present, non-standard use of antibiotics remains a common phenomenon in the treatment of preterm infants with early-onset sepsis (EOS) in China. The expert panel of neonatologists in Hunan Province formulated a consensus on the diagnosis and use of antibiotics for EOS in preterm infant [Chin J Contemp Pediatr, 2020, 22(1): 1-6], which has a positive effect on the rational use of antibiotics. Based on this consensus, this article points out that in order to use antibiotics accurately, it is necessary to accurately identify EOS in preterm infants, accurately understand their clinical manifestations and medical history, and accurately evaluate the laboratory test results. Also, this article offers suggestions for the use of antibiotics in preterm infants with EOS.
Age of Onset
;
Anti-Bacterial Agents
;
therapeutic use
;
China
;
Humans
;
Infant, Newborn
;
Infant, Premature
;
Infant, Premature, Diseases
;
Risk Factors
;
Sepsis
;
drug therapy
6.Association between fruit and vegetable allergies and pollen-food allergy syndrome in Japanese children: a multicenter cross-sectional case series
Yutaka TAKEMURA ; Yuri TAKAOKA ; Tomoyuki ARIMA ; Hiroki MASUMI ; Koji YAMASAKI ; Megumi NAGAI ; Keisuke SUGIMOTO ; Masaaki HAMADA ; Tomoko TAKANO ; Masaaki DOI ; Tomoko KAWAKAMI ; Makoto KAMEDA
Asia Pacific Allergy 2020;10(1):9-
BACKGROUND: Recently, the prevalence of food allergies during childhood is increasing, with fruits being common allergens. However, data on allergens that cause fruit and vegetable allergies and pollen-food allergy syndrome (PFAS) in childhood are relatively few. This study aimed to examine the allergens in fruit and vegetable allergies in pediatric patients and to determine the association between fruit and vegetable allergies and PFAS.OBJECTIVE: This study aimed to examine the current status of fruit and vegetable allergies in Japanese children.METHODS: This was a multicenter case series observational study. The participants included children aged <15 years who developed allergic symptoms after eating fruits and vegetables and subsequently received treatment in the Pediatric Department of 6 hospitals in the Osaka Prefecture in Japan during the study period from August 2016 to July 2017. Participants' information was obtained using a questionnaire, and data were obtained by performing several types of allergy tests using blood samples.RESULTS: A total of 97 children (median age, 9 years; 56 males) were included in the study. Apple was the most common allergen, followed by peach, kiwi, cantaloupe, and watermelon. A total of 74 participants (76%) exhibited allergic symptoms due to PFAS; moreover, pathogenesis-related protein-10 (PR-10) was the most common allergen superfamily. On the contrary, in the group where neither PR-10 nor profilin was sensitized, kiwi and banana were the most common allergens, and the age of onset was lower than that in the PFAS group. Specific antibody titer was significantly associated with Birch for Bet v1 and latex for Bet v2 (r = 0.99 and r = 0.89).CONCLUSION: When we examine patients with fruit and vegetable allergies, we should first consider PFAS even in childhood specifically for children greater than 4 years old.
Age of Onset
;
Allergens
;
Asian Continental Ancestry Group
;
Betula
;
Child
;
Citrullus
;
Clinical Study
;
Cucumis melo
;
Eating
;
Food Hypersensitivity
;
Fruit
;
Humans
;
Hypersensitivity
;
Japan
;
Latex
;
Musa
;
Observational Study
;
Prevalence
;
Profilins
;
Prunus persica
;
Rhinitis
;
Rhinitis, Allergic, Seasonal
;
Vegetables
7.Clinical features of children with immunodeficiency and
Chinese Journal of Contemporary Pediatrics 2020;22(12):1300-1305
OBJECTIVE:
To study the clinical features of
METHODS:
A retrospective analysis was performed on the medical data of children with immunodeficiency and
RESULTS:
The onset age in the PID group was significantly lower than those in the control and SID groups (
CONCLUSIONS
Children with immunodeficiency and
Age of Onset
;
Child
;
Humans
;
Immunologic Deficiency Syndromes/diagnosis*
;
Male
;
Retrospective Studies
;
Tuberculin Test
;
Tuberculosis/epidemiology*
8.Genotype-phenotype correlations in pediatric patients with myotonic dystrophy type 1
Hyeong Jung KIM ; Ji Hoon NA ; Young Mock LEE
Korean Journal of Pediatrics 2019;62(2):55-61
PURPOSE: Myotonic dystrophy, also known as dystrophia myotonica (DM), is an autosomal dominant disorder with 2 genetically distinct forms. DM type 1 (DM1) is the more common form and is caused by abnormal expansion of cytosine/thymine/guanine (CTG) repeats in the DM protein kinase (DMPK) gene. Our study aimed to determine whether the age of onset is correlated with CTG repeat length in a population of pediatric patients with DM1. METHODS: We retrospectively identified 30 pediatric patients with DM1 that underwent DMPK testing, of which the clinical data of 17 was sufficient. The cohort was divided into 2 subgroups based on the clinical phenotype (congenital-onset vs. late-onset) and number of CTG repeats ( < 1,000 vs. ≥1,000). RESULTS: We found no significant difference between the age of onset and CTG repeat length in our pediatric patient population. Based on clinical subgrouping, we found that the congenital-onset subgroup was statistically different with respect to several variables, including prematurity, rate of admission to neonatal intensive care unit, need for respiratory support at birth, hypotonia, dysphagia, ventilator dependence, and functional status on last visit, compared to the late-onset subgroup. Based on genetic subgrouping, we found a single variable (poor feeding in neonate) that was significantly different in the large CTG subgroup than that in the small CTG subgroup. CONCLUSION: Clinical variables exhibiting statistically significant differences between the subgroups should be focused on prognosis and designing tailored management approaches for the patients; our findings will contribute to achieve this important goal for treating patients with DM1.
Age of Onset
;
Cohort Studies
;
Deglutition Disorders
;
Genetic Association Studies
;
Genotype
;
Humans
;
Infant, Newborn
;
Intensive Care, Neonatal
;
Muscle Hypotonia
;
Myotonic Dystrophy
;
Myotonin-Protein Kinase
;
Parturition
;
Phenotype
;
Prognosis
;
Retrospective Studies
;
Ventilators, Mechanical
9.Comparative Study of Clinical Features between Early- and Late-Onset Schizophrenia in South Korea
Mi Ae KO ; Seon Koo LEE ; Jung Suk LEE
Korean Journal of Schizophrenia Research 2019;22(2):51-55
OBJECTIVES: Late-onset schizophrenia (LOS, age at first onset ≥40 years) is characterized by including predominance of women, better premorbid social adjustment and lower severity of positive/negative symptoms. However, few studies have been conducted on LOS, especially in Asian countries. This study aimed to examine the clinical features of LOS in comparison with early-onset schizophrenia (EOS). METHODS: By retrospectively reviewing medical records, we assessed demographic data and clinical features of 76 LOS (20 males) and 357 EOS (144 males) who admitted to the psychiatric ward of a general hospital. RESULTS: The mean ages of onset were 47.3±5.1 (LOS) and 25.7±6.5 (EOS) years. There were significantly more women in LOS (73.7%) than EOS (59.6%). Significantly more LOS patients had a marital (88.2% vs. 25.8%) and employment history (28.9% vs. 13.1%) than EOS. Patients with LOS had fewer negative (14.3±9.0 vs. 19.9±9.3), general psychopathology score (36.9±11.1 vs. 42.3±13.9) than EOS patients. CONCLUSION: In line with previous studies, this study demonstrated that LOS patients have better premorbid social adjustment. Our finding also replicates previous findings that LOS patients differ from EOS in predominance of women and relative lack of negative symptoms. These results suggest that LOS may be a distinct subtype of schizophrenia.
Age of Onset
;
Asian Continental Ancestry Group
;
Employment
;
Female
;
Hospitals, General
;
Humans
;
Korea
;
Medical Records
;
Psychopathology
;
Retrospective Studies
;
Schizophrenia
;
Sex Ratio
;
Social Adjustment
10.Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1
Marco CALABRÒ ; Laura MANDELLI ; Concetta CRISAFULLI ; Soo Jung LEE ; Tae Youn JUN ; Sheng Min WANG ; Ashwin A PATKAR ; Prakash S MASAND ; Changsu HAN ; Chi Un PAE ; Alessandro SERRETTI
Clinical Psychopharmacology and Neuroscience 2019;17(3):364-368
OBJECTIVE: Genetics factors are likely to play a role in the risk, clinical presentation and treatment outcome in major depressive disorder (MDD). In this study, we investigated the role of three candidate genes for MDD; calcium voltage-gated channel subunit alpha1 C (CACNA1C), cholinergic receptor nicotinic alpha 7 subunit (CHRNA7), and mitogen-activated protein kinase 1 (MAPK1). METHODS: Two-hundred forty-two MDD patients and 326 healthy controls of Korean ancestry served as samples for the analyses. Thirty-nine single nucleotide polymorphisms (SNPs) within CACNA1C, CHRNA7, and MAPK1 genes were genotyped and subsequently tested for association with MDD (primary analysis) and other clinical features (symptoms’ severity, age of onset, history of suicide attempt, treatment outcome) (secondary analyses). Single SNPs, haplotypes and epistatic analyses were performed. RESULTS: Single SNPs were not associated with disease risk and clinical features. However, a combination of alleles (haplotype) within MAPK1 was found associated with MDD-status. Secondary analyses detected a possible involvement of CACNA1C haplotype in resistance to antidepressant treatment. CONCLUSION: These data suggest a role for MAPK1 and CACNA1C in MDD risk and treatment resistance, respectively. However, since many limitations characterize the analysis, the results must be considered with great caution and verified.
Age of Onset
;
Alleles
;
Calcium
;
Depression
;
Depressive Disorder, Major
;
Genetics
;
Haplotypes
;
Humans
;
Mitogen-Activated Protein Kinase 1
;
Neuronal Plasticity
;
Polymorphism, Single Nucleotide
;
Suicide
;
Treatment Outcome


Result Analysis
Print
Save
E-mail